Medicare Enrolled
Dr. Joseph Tropea, DO
Hematology & Oncology · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tropea from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tropea?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tropea
Dr. Joseph Tropea is a hematology & oncology specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tropea performed 1,026 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Tropea received a total of $16,586 from 84 pharmaceutical and/or device companies across 633 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tropea is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 29% volume in PA
$16,586 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,026
Medicare services
Top 29% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
252 | $99 | $233 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
143 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
141 | $8 | $60 |
| New patient office visit, complex (60-74 min) | 110 | $177 | $480 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
73 | $138 | $427 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
70 | $23 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
59 | $11 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
41 | $108 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $13 | $95 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $66 | $151 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
29 | $46 | $165 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
27 | $1 | $3 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $128 | $308 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.6% high complexity
11.9% medium
74.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,586
Total received (2018-2024)
Avg $2,369/year across 7 years
Top 17% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
633
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,093
2023
$1,139
2022
$3,706
2021
$2,741
2020
$4,957
2019
$2,823
2018
$128
Payments by company (2024)
Daiichi Sankyo Inc.
$173
PFIZER INC.
$142
ABBVIE INC.
$141
E.R. Squibb & Sons, L.L.C.
$137
SOBI, INC
$116
AstraZeneca Pharmaceuticals LP
$52
Celgene Corporation
$52
Novartis Pharmaceuticals Corporation
$50
ARRAY BIOPHARMA INC
$45
Merck Sharp & Dohme LLC
$35
Gilead Sciences, Inc.
$34
Lilly USA, LLC
$30
Bayer Healthcare Pharmaceuticals Inc.
$22
ADC Therapeutics America, Inc.
$20
Eisai Inc.
$18
TAIHO ONCOLOGY, INC.
$14
Astellas Pharma US Inc
$14
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$2,100
AstraZeneca Pharmaceuticals LP
$1,127
Rigel Pharmaceuticals, Inc.
$1,092
Celgene Corporation
$696
Incyte Corporation
$662
Janssen Biotech, Inc.
$647
Daiichi Sankyo Inc.
$544
Seagen Inc.
$500
Amgen Inc.
$498
Janssen Pharmaceuticals, Inc
$477
Lilly USA, LLC
$451
GENZYME CORPORATION
$416
PFIZER INC.
$412
Novartis Pharmaceuticals Corporation
$405
Gilead Sciences, Inc.
$320
Regeneron Healthcare Solutions, Inc.
$316
EMD Serono, Inc.
$265
Genentech USA, Inc.
$264
Blueprint Medicines Corporation
$260
SANOFI-AVENTIS U.S. LLC
$258
Karyopharm Therapeutics Inc.
$235
Merck Sharp & Dohme Corporation
$209
Pharmacyclics LLC, An AbbVie Company
$197
ABBVIE INC.
$184
TerSera Therapeutics LLC
$183
Bayer HealthCare Pharmaceuticals Inc.
$178
Merck Sharp & Dohme LLC
$176
Puma Biotechnology, Inc.
$173
AbbVie Inc.
$170
BeiGene USA, Inc.
$165
Galvanize Therapeutics, Inc
$152
Verastem, Inc.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
Takeda Pharmaceuticals U.S.A., Inc.
$125
Dova Pharmaceuticals
$125
Bayer Healthcare Pharmaceuticals Inc.
$119
SOBI, INC
$116
Ipsen Biopharmaceuticals, Inc
$116
Astellas Pharma US Inc
$116
Kite Pharma, Inc.
$111
EISAI INC.
$110
Eisai Inc.
$109
Taiho Oncology, Inc.
$98
ARRAY BIOPHARMA INC
$83
Dendreon Pharmaceuticals LLC
$78
Global Blood Therapeutics, Inc.
$76
Kyowa Kirin, Inc.
$75
Teva Pharmaceuticals USA, Inc.
$75
Foundation Medicine, Inc.
$60
GlaxoSmithKline, LLC.
$60
Alexion Pharmaceuticals, Inc.
$52
Exelixis Inc.
$49
Secura Bio, Inc.
$47
Pharmacosmos Therapeutics Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$43
Coherus Biosciences Inc.
$38
MorphoSys, US Inc.
$38
Pharmacyclics LLC, an AbbVie Company
$37
Sobi, Inc
$36
Epizyme, Inc.,
$35
Lexicon Pharmaceuticals, Inc.
$33
Bio Products Laboratory USA, Inc.
$31
TAIHO ONCOLOGY, INC.
$31
Myriad Genetic Laboratories, Inc.
$26
TESARO, Inc.
$25
AVEO Pharmaceuticals, Inc.
$25
EUSA Pharma (US) LLC
$23
Seattle Genetics, Inc.
$23
G1 Therapeutics, Inc.
$22
Shire North American Group Inc
$22
Deciphera Pharmaceuticals Inc.
$21
Fresenius Kabi USA, LLC
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
ADC Therapeutics America, Inc.
$20
Mylan Institutional Inc.
$19
Genmab U.S., Inc.
$19
JAZZ PHARMACEUTICALS INC.
$19
Clovis Oncology, Inc.
$18
Adaptive Biotechnologies Corporation
$16
AMAG Pharmaceuticals, Inc.
$15
Agios Pharmaceuticals, Inc.
$14
AbbVie, Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Jazz Pharmaceuticals Inc.
$11
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALIYA SYSTEM · ALUNBRIG · AUGTYRO · AYVAKIT · Aliqopa · BALVERSA · BENDEKA · BLENREP · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Coagadex · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · Farydak · Fulphila · GAVRETO · GILOTRIF · Gammaplex · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kabiven · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SANCUSO · SARCLISA · SOMATULINE DEPOT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tepmetko · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · Vanflyta · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
280
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tropea is a clinical cardiology specialist, with above-average Medicare volume (top 29% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tropea experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tropea performed 252 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Tropea receive payments from pharmaceutical companies?
Yes. Dr. Tropea received a total of $16,586 from 84 companies across 633 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tropea's costs compare to other hematology & oncology specialists in Philadelphia?
Dr. Tropea's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tropea) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Philadelphia
Browse hematology & oncology specialists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology